Хайсян Фарма: Компания с участием Huayi Taikang подала заявку на публичное размещение акций для неопределенного круга квалифицированных инвесторов и их листинг на Северной бирже, заявка принята

Haixiang Pharmaceutical announced that the application of Huayi Taikang Pharmaceutical Co., Ltd., in which the company holds shares, for a public offering of stocks to unspecified qualified investors and listing on the Beijing Stock Exchange has been accepted by the Beijing Stock Exchange. Huayi Taikang received the “Acceptance Notice” issued by the Beijing Stock Exchange on March 31, 2026. As of the disclosure date of this announcement, Haixiang Pharmaceutical holds 1.112 million shares of Huayi Taikang, accounting for 1.85% of its total shares. Huayi Taikang’s listing application still requires approval from the Beijing Stock Exchange and registration approval from the China Securities Regulatory Commission, and the final outcome is uncertain.